Sponsor

CHU de Brest

France 2 Avenue Foch, 29200 Brest, France

About the sponsor

Clinical research at CHU de Brest includes chronic inflammatory and fibrosing diseases, with interest in identifying disease sites and patterns of tissue involvement through PET/CT imaging. The sponsor’s research activity is centered on conditions where inflammation and fibrosis overlap, supporting clinical evaluation in complex systemic disease.

Chronic inflammation
Fibrotic disease
Inflammatory tissue involvement
PET/CT imaging
Molecular imaging

Research interest extends to the assessment of disease distribution across multiple affected sites, with emphasis on imaging-based characterization of inflammatory and fibrosing pathology.

About Specializations

CHU de Brest runs clinical trials in conditions such as Inflammation, among others.

Inflammation

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Inflammation

Recruiting

Registered drugNo placebo

Study on 68Gallium-FAPI PET/CT Imaging for Patients with Chronic Inflammatory Disorders Using Gallium (68Ga) Chloride and 68-FAPI-46

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Sponsor:CHU de Brest

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →